María José Pérez-Sáez1, Daniel Prieto-Alhambra2, Clara Barrios1, Marta Crespo1, Dolores Redondo1, Xavier Nogués3, Adolfo Díez-Pérez4, Julio Pascual5. 1. Department of Nephrology, Hospital del Mar, Barcelona, Spain. 2. Institut Mar d'Investigacions Mediques, Barcelona, Spain; Idiap Jordi Gol Primary Care Research Institute, Universitat Autonoma de Barcelona, Barcelona, Spain; Musculoskeletal Epidemiology Unit, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK. Electronic address: daniel.prietoalhambra@ndorms.ox.ac.uk. 3. Department of Internal Medicine, Hospital del Mar, Barcelona, Spain. 4. Idiap Jordi Gol Primary Care Research Institute, Universitat Autonoma de Barcelona, Barcelona, Spain; Department of Internal Medicine, Hospital del Mar, Barcelona, Spain. 5. Department of Nephrology, Hospital del Mar, Barcelona, Spain; Idiap Jordi Gol Primary Care Research Institute, Universitat Autonoma de Barcelona, Barcelona, Spain.
Abstract
BACKGROUND: Many studies have shown a correlation between chronic kidney disease (CKD) and fracture. However, increased mortality in CKD patients is a competing risk scenario not accounted for in previous studies. Our aim was to investigate the true impact of CKD on hip fracture after accounting for a competing risk with death. METHODS: We conducted a population-based cohort study to determine the impact of CKD on hip fractures in individuals aged ≥50years old registered in the SIDIAP(Q) database (representative of 1.9 million people in Catalonia, Spain). Cox regression was used to estimate hazard ratio (HR) for death and hip fracture according to CKD status. A competing risk (Fine and Gray) model was fitted to estimate sub-HR for hip fracture in CKD or CKD-free patients accounting for differential mortality. RESULTS: A total of 873,073 (32,934 (3.8%) CKD) patients were observed for 3 years. During follow-up, 4,823 (14.6%) CKD and 36,328 (4.3%) CKD-free participants died (HR, 1.83 [95% CI, 1.78-1.89]), whilst 522 (1.59%) and 6,292 (0.75%) sustained hip fractures, respectively. Adjusted Cox models showed a significantly increased risk of hip fractures for the CKD group (HR, 1.16 [1.06-1.27]), but this association was attenuated in competing risk models accounting for mortality (SHR, 1.14 [1.03-1.27]). CONCLUSIONS: Both death and hip fracture rates are increased (by 83% and 16%, respectively) in CKD patients. However, the association between CKD and hip fractures is attenuated when an excess of mortality is taken into account. A competing risk with death must be considered in future analyses of association between CKD and any health outcomes.
BACKGROUND: Many studies have shown a correlation between chronic kidney disease (CKD) and fracture. However, increased mortality in CKD patients is a competing risk scenario not accounted for in previous studies. Our aim was to investigate the true impact of CKD on hip fracture after accounting for a competing risk with death. METHODS: We conducted a population-based cohort study to determine the impact of CKD on hip fractures in individuals aged ≥50years old registered in the SIDIAP(Q) database (representative of 1.9 million people in Catalonia, Spain). Cox regression was used to estimate hazard ratio (HR) for death and hip fracture according to CKD status. A competing risk (Fine and Gray) model was fitted to estimate sub-HR for hip fracture in CKD or CKD-freepatients accounting for differential mortality. RESULTS: A total of 873,073 (32,934 (3.8%) CKD) patients were observed for 3 years. During follow-up, 4,823 (14.6%) CKD and 36,328 (4.3%) CKD-freeparticipants died (HR, 1.83 [95% CI, 1.78-1.89]), whilst 522 (1.59%) and 6,292 (0.75%) sustained hip fractures, respectively. Adjusted Cox models showed a significantly increased risk of hip fractures for the CKD group (HR, 1.16 [1.06-1.27]), but this association was attenuated in competing risk models accounting for mortality (SHR, 1.14 [1.03-1.27]). CONCLUSIONS: Both death and hip fracture rates are increased (by 83% and 16%, respectively) in CKD patients. However, the association between CKD and hip fractures is attenuated when an excess of mortality is taken into account. A competing risk with death must be considered in future analyses of association between CKD and any health outcomes.
Authors: Rasheeda K Hall; Richard Sloane; Carl Pieper; Courtney Van Houtven; Joanne LaFleur; Robert Adler; Cathleen Colón-Emeric Journal: J Am Geriatr Soc Date: 2018-01-10 Impact factor: 5.562
Authors: Tamara Isakova; Timothy E Craven; Julia J Scialla; Thomas L Nickolas; Adrian Schnall; Joshua Barzilay; Ann V Schwartz Journal: Bone Date: 2015-04-30 Impact factor: 4.398
Authors: Diana Moldovan; Crina Rusu; Alina Potra; Ioan Moldovan; Ioan Mihai Patiu; Mirela Gherman-Caprioara; Ina Maria Kacso Journal: Int Urol Nephrol Date: 2017-02-04 Impact factor: 2.370
Authors: N A Goto; A C G Weststrate; F M Oosterlaan; M C Verhaar; H C Willems; M H Emmelot-Vonk; M E Hamaker Journal: Osteoporos Int Date: 2019-11-12 Impact factor: 4.507
Authors: Björn Runesson; Marco Trevisan; Ken Iseri; Abdul Rashid Qureshi; Bengt Lindholm; Peter Barany; Carl Gustaf Elinder; Juan Jesus Carrero Journal: Nephrol Dial Transplant Date: 2020-11-01 Impact factor: 5.992
Authors: I J A de Bruin; C E Wyers; P C Souverein; T P van Staa; P P M M Geusens; J P W van den Bergh; F de Vries; J H M Driessen Journal: Osteoporos Int Date: 2020-04-07 Impact factor: 4.507